• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ⅰ期非小细胞肺癌患者 CT 引导下微波消融治疗中肺实质出血和咯血的危险因素:一项多中心回顾性研究。

Risk factors for lung parenchyma hemorrhage and hemoptysis during computed tomography-guided microwave ablation in patients with stage I non-small cell lung cancer: A bicentric retrospective study.

机构信息

Department of Radiology, Qilu Hospital of Shandong University, Jinan, China.

Cheeloo College of Medicine, Shandong University, Jinan, China.

出版信息

Thorac Cancer. 2024 Nov;15(33):2386-2394. doi: 10.1111/1759-7714.15466. Epub 2024 Oct 13.

DOI:10.1111/1759-7714.15466
PMID:39396834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11586133/
Abstract

OBJECTIVES

This study aimed to identify the risk factors for lung parenchyma hemorrhage and hemoptysis during computed tomography-guided microwave ablation (MWA) in patients with stage I non-small cell lung cancer (NSCLC).

METHODS

A total of 417 patients from two medical centers were included, of whom 353 were from center 1 and 64 were from center 2. The risk factors for lung parenchyma hemorrhage and hemoptysis were selected by univariable and multivariable logistic analyses in the center 1 dataset. The selected risk factors were validated in the center 2 dataset.

RESULTS

The risk factors for lung parenchyma hemorrhage during MWA were focal blood supplies (odds ratio [OR], 2.602; 95% confidence interval [CI], 1.609-4.210; p < 0.001), near vessels larger than 2 mm (OR, 4.145; 95% CI, 1.963-8.755; p < 0.001), and traversing vessels in the track of ablation (OR, 2.961; 95% CI, 1.492-5.874; p = 0.002). The risk factors for hemoptysis were lung parenchyma hemorrhage (OR, 34.165; 95% CI, 12.255-95.247; p < 0.001), needle track traversing the lung parenchyma by >25 mm (OR, 4.494; 95% CI, 1.833-11.018; p = 0.001), and traversing vessels in the track of ablation (OR, 5.402; 95% CI, 2.269-12.865; p < 0.001).

CONCLUSIONS

Focal blood supplies, near vessels larger than 2 mm, and traversing vessels in the track of ablation were independent risk factors for lung parenchyma hemorrhage during MWA. Lung parenchyma hemorrhage, needle track traversing the lung parenchyma by >25 mm, and traversing vessels in the track of ablation were independent risk factors for hemoptysis during MWA.

摘要

目的

本研究旨在确定Ⅰ期非小细胞肺癌(NSCLC)患者行 CT 引导下微波消融(MWA)时肺实质出血和咯血的危险因素。

方法

共纳入来自 2 个医学中心的 417 例患者,其中 353 例来自中心 1,64 例来自中心 2。采用单变量和多变量逻辑分析方法在中心 1 数据集选择肺实质出血和咯血的危险因素。在中心 2 数据集验证选择的危险因素。

结果

MWA 时肺实质出血的危险因素为局灶性血供(优势比 [OR],2.602;95%置信区间 [CI],1.609-4.210;p<0.001)、距离大于 2mm 的近血管(OR,4.145;95%CI,1.963-8.755;p<0.001)和消融路径中的穿行血管(OR,2.961;95%CI,1.492-5.874;p=0.002)。咯血的危险因素为肺实质出血(OR,34.165;95%CI,12.255-95.247;p<0.001)、针道穿透肺实质>25mm(OR,4.494;95%CI,1.833-11.018;p=0.001)和消融路径中的穿行血管(OR,5.402;95%CI,2.269-12.865;p<0.001)。

结论

局灶性血供、距离大于 2mm 的近血管和消融路径中的穿行血管是 MWA 时肺实质出血的独立危险因素。肺实质出血、针道穿透肺实质>25mm 和消融路径中的穿行血管是 MWA 时咯血的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/c3b49029ccf7/TCA-15-2386-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/90ed3fd24ea2/TCA-15-2386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/0ac12905a106/TCA-15-2386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/c3b49029ccf7/TCA-15-2386-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/90ed3fd24ea2/TCA-15-2386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/0ac12905a106/TCA-15-2386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f573/11586133/c3b49029ccf7/TCA-15-2386-g004.jpg

相似文献

1
Risk factors for lung parenchyma hemorrhage and hemoptysis during computed tomography-guided microwave ablation in patients with stage I non-small cell lung cancer: A bicentric retrospective study.Ⅰ期非小细胞肺癌患者 CT 引导下微波消融治疗中肺实质出血和咯血的危险因素:一项多中心回顾性研究。
Thorac Cancer. 2024 Nov;15(33):2386-2394. doi: 10.1111/1759-7714.15466. Epub 2024 Oct 13.
2
Surgical Outcomes of Video-Assisted Thoracic Surgery Combined With Computed Tomography-Guided Microwave Ablation for Lung Cancer Presenting as Multiple Ground-Glass Opacities: A 5-Year Retrospective Cohort Study.电视辅助胸腔镜手术联合计算机断层扫描引导下微波消融治疗表现为多发磨玻璃影的肺癌的手术结果:一项5年回顾性队列研究
Thorac Cancer. 2025 Jul;16(14):e70120. doi: 10.1111/1759-7714.70120.
3
Systematic Review of Image-Guided Thermal Ablation for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.影像引导热消融治疗Ⅰ期高危非小细胞肺癌患者的系统评价
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):82-88. doi: 10.1053/j.semtcvs.2024.11.001. Epub 2024 Dec 9.
4
Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment.微波消融作为局部巩固治疗用于一线 EGFR-TKIs 治疗后无进展的颅外寡转移 EGFR 突变型非小细胞肺癌患者。
J Cancer Res Clin Oncol. 2020 Jan;146(1):197-203. doi: 10.1007/s00432-019-03043-6. Epub 2019 Oct 10.
5
CT-Guided Lung Biopsy with Needle Embolization Using Gelatin Sponge Slurry to Prevent Pneumothorax and Pulmonary Hemorrhage: A Propensity Score Matching Controlled Study.CT引导下经皮肺穿刺活检联合明胶海绵混悬液针道栓塞预防气胸和肺出血:一项倾向评分匹配对照研究
Acad Radiol. 2025 Sep;32(9):5533-5544. doi: 10.1016/j.acra.2025.04.055. Epub 2025 May 13.
6
Efficacy and safety of CT-guided microwave ablation for stage I non-small cell lung cancer in elderly patients.CT引导下微波消融治疗老年Ⅰ期非小细胞肺癌的疗效与安全性
Cancer Imaging. 2025 Aug 15;25(1):100. doi: 10.1186/s40644-025-00925-6.
7
Effectiveness of Track Cauterization in Reduction of Adverse Events for Lung Microwave Ablation.轨迹烧灼术在减少肺部微波消融不良事件中的有效性。
J Vasc Interv Radiol. 2025 Jan;36(1):58-65.e1. doi: 10.1016/j.jvir.2024.08.029. Epub 2024 Oct 9.
8
Microwave Ablation of Refractory Oligometastatic Non-Small Cell Lung Cancer in the Liver.肝脏中难治性寡转移非小细胞肺癌的微波消融术
J Vasc Interv Radiol. 2025 Feb;36(2):266-273. doi: 10.1016/j.jvir.2024.10.017. Epub 2024 Oct 22.
9
Machine Learning Based on Clinical Information and Integrated CT Radiomics to Predict Local Recurrence of Stage Ia Lung Adenocarcinoma after Microwave Ablation.基于临床信息和整合 CT 放射组学的机器学习预测 Microwave Ablation 后 Ia 期肺腺癌局部复发。
J Vasc Interv Radiol. 2024 Dec;35(12):1823-1832.e3. doi: 10.1016/j.jvir.2024.08.018. Epub 2024 Aug 28.
10
Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.临床Ⅰ期非小细胞肺癌延迟手术治疗与肿瘤学结局分析。
JAMA Netw Open. 2021 May 3;4(5):e2111613. doi: 10.1001/jamanetworkopen.2021.11613.

引用本文的文献

1
Synchronous percutaneous microwave ablation combined with percutaneous biopsy for highly suspected malignant pulmonary nodules: a retrospective study.同步经皮微波消融联合经皮活检用于高度怀疑的恶性肺结节:一项回顾性研究
J Thorac Dis. 2025 Jul 31;17(7):4768-4781. doi: 10.21037/jtd-2025-105. Epub 2025 Jul 27.

本文引用的文献

1
SPACES: Our team's experience in lung tumor microwave ablation.空间:我们团队在肺肿瘤微波消融方面的经验。
J Cancer Res Ther. 2023 Feb;19(1):1-13. doi: 10.4103/jcrt.jcrt_70_23.
2
Microwave ablation for the control of bleeding from disintegrated mammary tumours in two dogs.微波消融治疗 2 只犬乳腺肿瘤破碎后出血的疗效观察
Vet Med Sci. 2023 May;9(3):1062-1068. doi: 10.1002/vms3.1089. Epub 2023 Feb 6.
3
Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition).原发性和转移性肺肿瘤影像引导热消融临床实践指南(2022年版)
J Cancer Res Ther. 2022 Sep;18(5):1213-1230. doi: 10.4103/jcrt.jcrt_880_22.
4
Computed tomography-guided microwave ablation for non-small cell lung cancer patients on antithrombotic therapy: a retrospective cohort study.计算机断层扫描引导下微波消融治疗接受抗血栓治疗的非小细胞肺癌患者:一项回顾性队列研究
Quant Imaging Med Surg. 2022 Jun;12(6):3251-3263. doi: 10.21037/qims-21-1043.
5
Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results.微波消融治疗无法手术的 I 期非小细胞肺癌:长期结果。
Eur Radiol. 2022 Aug;32(8):5616-5622. doi: 10.1007/s00330-022-08615-8. Epub 2022 Feb 28.
6
Influences of blood flow parameters on temperature distribution during liver tumor microwave ablation.血流参数对肝肿瘤微波消融过程中温度分布的影响
Front Biosci (Landmark Ed). 2021 Sep 30;26(9):504-516. doi: 10.52586/4963.
7
Using a risk model for probability of cancer in pulmonary nodules.应用于肺结节癌症概率的风险模型。
Thorac Cancer. 2021 Jun;12(12):1881-1889. doi: 10.1111/1759-7714.13991. Epub 2021 May 11.
8
Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.手术切除与 CT 引导下经皮消融治疗 I 期非小细胞肺癌(NSCLC)的生存结局:系统评价和荟萃分析。
Eur Radiol. 2021 Jul;31(7):5421-5433. doi: 10.1007/s00330-020-07634-7. Epub 2021 Jan 15.
9
Risk factors associated with pulmonary hemorrhage and hemoptysis following percutaneous CT-guided transthoracic lung core needle biopsy: a retrospective study of 1,090 cases.经皮CT引导下经胸肺穿刺活检术后肺出血和咯血的相关危险因素:1090例回顾性研究
Quant Imaging Med Surg. 2020 May;10(5):1008-1020. doi: 10.21037/qims-19-1024.
10
Pneumothorax and pulmonary hemorrhage after CT-guided lung biopsy: incidence, clinical significance and correlation.CT 引导下肺活检后气胸和肺出血:发生率、临床意义及相关性。
Radiol Med. 2021 Jan;126(1):170-177. doi: 10.1007/s11547-020-01211-0. Epub 2020 May 6.